316 results on '"Robinson, C.G."'
Search Results
2. Magnetic Resonance Image-Guided Radiotherapy (MRIgRT): A 4.5-Year Clinical Experience
3. Temporospatial Feathering of Hot Spots for Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Ultra-Central Thorax
4. Radiotherapy Dose as a Predictor of Outcomes Following Cardiac Radioablation for High-risk Refractory VT
5. The Impact of Intra-Fraction Bowel Motion on Luminal Gastrointestinal Organ at Risk Dosimetry When Using Stereotactic Adaptive Radiotherapy for Abdominal Malignancies
6. Circulating Tumor DNA for Early Risk Stratification of Oligometastatic Lung Cancer
7. In Silico Trial of Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Abdominal Oligometastases
8. A Prospective Feasibility Study Evaluating Skin Surface-Guided Gating as a Method to Manage Intrafraction Motion for Stereotactic Body Radiotherapy on a Novel Ring Gantry Machine
9. Dosimetric Predictors of Acute and Late Gastrointestinal Toxicities in Stereotactic Online Adaptive Magnetic Resonance-Guided Radiotherapy (SMART) for Locally Advanced Pancreatic Adenocarcinoma
10. avb6 Integrin-Targeted PET Imaging to Monitor Radiation-Induced Pulmonary Fibrosis In Vivo
11. CT-Guided Adaptive Radiotherapy (CT-ART) Improves Target Coverage in Hypofractionated Radiation Therapy for Bladder Cancer
12. Surface Imaging-Guided Adaptive Radiotherapy (ART): Imaging Protocol and Verification for Inter- and Intra-Fractional Motion Managements
13. Final Results of an International Delphi Consensus Study Regarding the Optimal Management of Radiation Pneumonitis
14. CT-Based Online Adaptive Prostate SBRT Improves Target Coverage and Reduces Rectal Dose
15. In-Silico Trial of Simulation-Free Hippocampal-Avoidance Whole Brain Radiotherapy Using Diagnostic MRI-Based and Online Adaptive Planning
16. Clinical Workflow for Planning and Treating Palliative Patients on Diagnostic Images
17. Brain Metastases in Metastatic Cutaneous Melanoma: Patterns of Care and Clinical Outcomes in the Era of Immunotherapy and Targeted Therapy
18. Impact of ITV/GTV Ratio on Local Failure in Early Stage Non-Small Cell Lung Cancer Patients Receiving Stereotactic Ablative Radiation Therapy
19. The Influence of Neighborhood Socioeconomic Status and Follow-up on Survival in Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy
20. Enabling Best Practices for Cardiac Radioablation Through a Remote Education and Peer Review Program
21. Post-Operative Radiation Therapy for Non-Small Cell Lung Cancer Patients With Higher Positive to Examined Lymph Node Ratio is Associated With Improved Overall Survival
22. OA17.05 Association Between Pre-Treatment Circulating Immune Biomarkers And Survival In Stage III NSCLC: A Translational Analysis From NRG-RTOG 0617
23. OA17.04 Long-Term Outcomes by Radiation Technique for Locally-Advanced Non-small Lung Cancer: A Secondary Analysis of NRG Oncology-RTOG 0617 at 5-years
24. Product Costing—An Essential Element for Success in Bare Board Manufacture
25. P49.03 Chemoradiation with Cisplatin-Etoposide versus Carboplatin-Etoposide in Limited-Stage Small Cell Lung Cancer
26. MA13.01 A Validation Study on DNA Repair Gene Variant for Lung Cancer Survival Prediction after Chemoradiation: A Secondary Analysis for RTOG-0617 Study
27. Dosimetric Impact of Online Adaptive Radiotherapy on a Phase II Study of Hypofractionated Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer.
28. Clinical Outcomes And Radiologic Response Of Incompletely Resected Grade 2-3 Meningiomas Treated With External Beam Radiation Therapy
29. Amiodarone Use and Radiation Pneumonitis in Patients Undergoing Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer
30. Increased Rates of Serious Adverse Events among Stage I Non-small Cell Lung Cancer Surgical Patients who were Predicted to Receive Stereotactic Body Radiation Therapy by Treatment Allocation Modeling
31. Plan Quality And Fidelity Evaluation Of CBCT-Guided Stereotactic Online Adaptive Radiotherapy (CT-STAR) With An Artificial Intelligence (AI) Aided Plan Re-Optimization
32. A Single-Institution Phase I Feasibility Study of Dose-Escalated IMRT for Non-Operative Locally Advanced Esophageal Carcinoma
33. Comparing Prospective Quality of Life Assessments Among Clinical Stage I Non-Small Cell Lung Cancer Patients Receiving Surgery versus Stereotactic Body Radiation Therapy at One Year
34. Feasibility of Expediting Radiotherapy Clinical Workflow by Planning on Diagnostic Images and Adapting on a Commercial Adaptive Radiotherapy System
35. Evaluation of Target Motion Surrogate Suitability for Cardiac Radioablation of Ventricular Tachycardia
36. Management of Radiation Related Complications after Noninvasive Cardiac Radioablation
37. Development of and FMEA-based Risk Minimization for a Novel Tele-adaptive Radiotherapy System
38. Physician Variability in Target Volume Selection for the Treatment of Ventricular Tachycardia Using Noninvasive Cardiac Radioablation
39. RTOG0617 to Externally Validate Blood Cell ERCC1/2 Genotypic Signature as a Radiosensitivity Biomarker for Both Tumor and Normal Tissue for Individualized Dose Prescription
40. Semi-Automated Hippocampal Sparing Avoidance Whole-Brain Radiotherapy Using a Commercially Available Artificial Intelligence Toolkit
41. Novel Monte-Carlo Based IMPT Technique Utilizing Multi-Leaf Collimators on a Gantry Mounted Synchrocyclotron for Cardiac Radioablation of Ventricular Tachycardia Substrate.
42. Steep Dose-response Relationship between Maximum Hippocampal Dose and Memory Deficits following Hippocampal Avoidance Whole Brain Radiation Therapy (HA-WBRT) for Brain Metastases: A Secondary Analysis of NRG/RTOG 0933
43. Evaluation and Validation of Artificial Intelligence (AI) Delineation Models for CBCT-guided Stereotactic Online Adaptive Radiotherapy (STAR) Targeting Upper Abdominal Malignancies
44. Longer Term Results from a Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia (ENCORE-VT)
45. Significant Preservation of Neurocognitive Function (NCF) and Patient-Reported Symptoms with Hippocampal Avoidance (HA) during Whole-Brain Radiotherapy (WBRT) for Brain Metastases: Final Results of Nrg Oncology CC001
46. Radiomic Biomarkers Evaluation of the High Dose Arm of RTOG 0617
47. Invasive Nodal Staging May Not Reduce Regional and Distant Recurrence Rates for Patients Treated with SBRT for Inoperable Stage I NSCLC
48. Comparison of Insurance Payer Policies for Stereotactic Radiosurgery (SRS) in the US Based on the ASTRO Model Policy
49. Long-Term Survival without Systemic and Immune Therapy after Synchronous Thoracic and Brain Stereotactic Radiation for Oligometastatic NSCLC
50. Feasibility of Expediting Radiotherapy Clinical Workflow by Radiation Planning on Diagnostic Images
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.